WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
US$ 12,56
arrow_upward
+0,48%(+0,060) 1D
16 okt, 16:00:00 GMT-4 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor WXXWY genereren…
Openen
US$ 12,29
Hoog
US$ 12,56
Laag
US$ 12,20
Beursw.
198,43 mld.
Gem. vol.
61,89K
Volume
110,85K
52 wk hoog
US$ 14,80
52 wk laag
US$ 7,30
Bèta
0,01
Uitstaande aandelen
2,06 mld.
Aantal medewerkers
15K
Openen
US$ 12,29
Hoog
US$ 12,56
Laag
US$ 12,20
Beursw.
198,43 mld.
Gem. vol.
61,89K
Volume
110,85K
52 wk hoog
US$ 14,80
52 wk laag
US$ 7,30
Bèta
0,01
Uitstaande aandelen
2,06 mld.
Aantal medewerkers
15K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Headliner.nl
·
1 minuut geleden
Amerikaanse aandelenfutures herstellen voor grote tech-resultaten die AI-handel testen
Vietnam.vn
·
1 dag geleden
De S&P 500 kende de scherpste wekelijkse daling sinds juni 2026.
De Belegger
·
2 dagen geleden
Vergeet de 504 namen, vijf megacaps sturen deze S&P 500-ETF
Invezz
·
2 dagen geleden
Dow verliest 189 punten nu AI-aandelen dalen en olieprijzen stijgen
Profiel
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Over Wuxi Biologics Cayman ADR